Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TMR Post-Market Study Should Evaluate Long-Term Efficacy - FDA Panel

This article was originally published in The Gray Sheet

Executive Summary

Postmarket surveillance of PLC Medical's Heart Laser transmyocardial revascularization (TMR) device should address the long-term reproducibility of its safety and efficacy and further assess mortality associated with the system, FDA's Circulatory System Devices Panel recommended April 24 at its meeting in Gaithersburg, Maryland.
Advertisement

Related Content

Edwards/PLC Medical Deal Shows Confidence in Laser Angina Therapy
Edwards/PLC Medical Deal Shows Confidence in Laser Angina Therapy
Advertisement
UsernamePublicRestriction

Register

MT009998

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel